Jeremy Grantham Medpace Holdings, Inc. Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $27.2 Billion
- Q1 2024
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 34,805 shares of MEDP stock, worth $13.4 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
34,805
Previous 51,565
32.5%
Holding current value
$13.4 Million
Previous $15.8 Million
11.01%
% of portfolio
0.05%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding MEDP
# of Institutions
621Shares Held
25.1MCall Options Held
154KPut Options Held
117K-
Vanguard Group Inc Valley Forge, PA2.5MShares$968 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.49MShares$963 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT974KShares$376 Million2.07% of portfolio
-
Invesco Ltd. Atlanta, GA816KShares$315 Million0.07% of portfolio
-
State Street Corp Boston, MA697KShares$269 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $12B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...